Use of Daptomycin to Manage Severe MRSA Infections in Humans

Use of Daptomycin to Manage Severe MRSA Infections in Humans

Methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) represents a major therapeutic challenge due to its multidrug-resistance and the associated clinical burden. Daptomycin (DAP), a cyclic lipopeptide antibiotic, has become a key agent for the treatment of severe MRSA infections owi...

Full description

Saved in:
Bibliographic Details
Main Authors: Marco Fiore, Aniello Alfieri, Daniela Fiore, Pasquale Iuliano, Francesco Giuseppe Spatola, Andrea Limone, Ilaria Pezone, Sebastiano Leone
Format: Article
Language:English
Published: MDPI AG 2025-06-01
Series:Antibiotics
Subjects:
methicillin-resistant <i>Staphylococcus aureus</i>
daptomycin
antibiotic resistance
combination therapy
bacteremia
Online Access:https://www.mdpi.com/2079-6382/14/6/617
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/2079-6382/14/6/617

Similar Items